<!doctype html><html><head><meta charset=utf-8><title>15.3 X fewer COVID deaths in those getting Vitamin D injections in ICU – RCT</title>
<link rel=stylesheet href="/css/main.css?v=1748384335"><link rel=stylesheet href="/css/pagination.css?v=1748384335"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748384335"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>15.3 X fewer COVID deaths in those getting Vitamin D injections in ICU – RCT</h1><time>July 22, 2024</time><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#impact-of-rapid-correction-of-vitamin-d-deficiency-on-patients-with-covid-19-disease-a-randomized-controlled-trial>Impact of Rapid Correction of Vitamin D Deficiency on Patients with COVID-19 Disease: A Randomized-Controlled Trial</a></li></ul></li></ul></li></ul></nav><hr><h4 id=impact-of-rapid-correction-of-vitamin-d-deficiency-on-patients-with-covid-19-disease-a-randomized-controlled-trial>Impact of Rapid Correction of Vitamin D Deficiency on Patients with COVID-19 Disease: A Randomized-Controlled Trial</h4><p>The Egyptian Journal of Hospital Medicine (July 2024) Vol. 96, Page 2538-2546</p><p>Ayman Ramadan Abdelhai 1, Amir Abd-Elhameed Ahmed Barakat 1,</p><p>Marwa M. Esawy 2, May M. Sami 2, Ahmed Ibrahim Gad1</p><p>Departments of 1 Internal Medicine, 2 Clinical Pathology, Faculty of Medicine, Zagazig University, Egypt</p><hr><h5 id=summary-and-notes-by-vitamindwiki>Summary and notes by VitaminDWiki</h5><ul><li><p>4 days of 200,000 IU Vitamin D intramuscular injections while in ICU for COVID</p></li><li><p>The “control group” got 10,000 IU daily for 4 days</p></li><li><p>Vitamin D <a href=/categories/injection>Injections</a> act slowly – better to have fast-acting <a href=/posts/sublingual-vitamin-d style=color:red;text-decoration:underline title="This post/category does not exist yet: Sublingual vitamin D">Sublingual vitamin D</a> for 4 days</p></li><li><p>Would have been much better if patients had gotten Vitamin D BEFORE entering in ICU</p></li><li><p>Vitamin D level achieved: 32 ng. Even less <a href=/posts/mortality style=color:red;text-decoration:underline title="This post/category does not exist yet: Mortality">Mortality</a> expected if they had used larger doses (and get >40 ng)</p></li><li><p>Founder of VitaminDWiki bought >20 lbs of Vitamin D in 2020 to give away free - but could not find a single taker</p></li><li><p>Founder of VitaminDWiki tried to start an RCT in 2020 using 400,000 IU of vitamin D, but was stopped by local corruption</p></li></ul><hr><img src=https://d1bk1kqxc0sym.cloudfront.net/attachments/webp/200k-covid-table.webp alt=image width=400><p>Background: Although antiviral properties of vitamin D are recognized, the influence of parental Vit D supplementation</p><p>on COVID-19 disease has not been determined.</p><p>Objective: The aim of study was to evaluate impact of prompt treatment of Vit D deficiency on COVID-19 patients.</p><p>Patients and Methods: A randomized controlled experiment was carried out on 250 COVID-19 patients. Patients were</p><p>categorized into two cohorts: one cohort received daily intramuscular injection of 200,000 IU cholecalciferol for four</p><p>consecutive days, while other cohort received daily oral dose of 10,000 IU cholecalciferol. The latter group functioned as</p><p>control group. Before and after therapy, serum 25(OH)D level, inflammatory markers and electrolytes were measured,</p><p>besides, clinical follow-up.</p><p>Results: In Vit D group, the 25(OH)D levels considerably increased after 7 days compared to initial levels (32.48 ±9.64 Vs</p><p>13.77 ±6.51 ng/mL, respectively). All Vit D deficient patients have transitioned to sufficient status. Levels of markers (ESR</p><p>50.99±17.56 mm/hr, CRP 30.75 ±24 mg/L, and ferritin 392.05 ±139.17 ng/mL) decreased after seven days (29.74±8.97</p><p>mm/hr, 10.52 ±13 mg/L, and 94.59 ±27.14 ng/mL, respectively). A substantial clinical improvement occurred in Vit D</p><p>group compared to their initial condition.</p><p>Also Vit D deficiency was found to significantly increase risk of COVID-19 mortality by factor of <strong>15.375</strong> <span>[AOR = 15.375, 95% CI: 1.898-124.52, p=0.01]</span>.</p><p>Conclusion: A daily intramuscular injection of 200,000 IU cholecalciferol for four consecutive days has been proven to</p><p>significantly enhance clinico-labatory parameters in COVID-19 patients. Considering higher Vit D supplementation as</p><p>a potential treatment for COVID-19 is a viable option</p><p><strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/vit-d-injection-covid-compresspdf.pdf>Download the PDF from VitaminDWiki</a></strong></p><hr><h5 id=33-references>33 REFERENCES</h5><ol><li><p>Alhazzani W, Moller M, Arabi Y et al. (2020): Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med., 46:854-87.</p></li><li><p>Zhang R, Li B, Gao X et al. (2017): Serum 25- hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr., 105:810-9.</p></li><li><p>Zisi D, Challa A, Makis A (2019): The association between vitamin D status and infectious diseases of the respiratory system in infancy and childhood. Hormones (Athens), 18:353-63.</p></li><li><p>Holick M, Binkley N, Bischoff-Ferrari H et al. (2011): Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab., 96:1911-30.</p></li><li><p>Merzon E, Tworowski D, Gorohovski A et al. (2020): Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. Febs J., 287:3693-702.</p></li><li><p>Roth D, Abrams S, Aloia J et al. (2018): Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N Y Acad Sci., 1430:44-79.</p></li><li><p>Botros R, Sabry I, Abdelbaky R et al. (2015): Vitamin D deficiency among healthy Egyptian females. Endocrinol Nutr., 62:314-21.</p></li><li><p>Hurwitz J, Jones B, Penkert R et al. (2017): Low retinol­binding protein and vitamin D levels are associated with severe outcomes in children hospitalized with lower respiratory tract infection and respiratory syncytial virus or human metapneumovirus detection. J Pediatr., 187:323-7.</p></li><li><p><strong>Grant W, Lahore H, McDonnell</strong> S et al. (2020): Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients, 12:3533-9.</p></li><li><p>Ilie P, Stefanescu S, Smith L (2020): The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res., 32:1195-8.</p></li><li><p>Daneshkhah A, Eshein A, Subramanian H et al. (2020): The role of vitamin D in suppressing cytokine storm in COVID-19 patients and associated mortality. MedRxiv., 12:9.</p></li><li><p>Ezeamama A, Guwatudde D, Wang M et al. (2016): Vitamin-D deficiency impairs CD4+T-cell count recovery rate in HIV-positive adults on highly active antiretroviral therapy: A longitudinal study. Clin Nutr., 35:1110-7.</p></li><li><p>Adams J, Ren S, Liu P et al. (2009): Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol., 182:4289-95.</p></li><li><p>Gombart AF, Pierre A, Maggini S (2020): A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients, 12:33-36.</p></li><li><p>Shabana M, Esawy M, Ismail N et al. (2019): Predictive role of IL-17A/IL-10 ratio in persistent asthmatic patients on vitamin D supplement. Immunobiology, 224:721-7.</p></li><li><p>Jafarzadeh A, Chauhan P, Saha B et al. (2020): Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci., 257:118102.</p></li><li><p>Suaini N, Zhang Y, Vuillermin P et al. (2015): Immune modulation by vitamin D and its relevance to food allergy. Nutrients, 7:6088-108.</p></li><li><p>Greiller C, Martineau A (2015): Modulation of the immune response to respiratory viruses by vitamin D. Nutrients, 7:4240-70.</p></li><li><p>Hathcock J, Shao A, Vieth R et al. (2007): Risk assessment for vitamin D. Am J Clin Nutr., 85:6-18.</p></li><li><p>Haimovich A, Ravindra N, Stoytchev S et al. (2020): Development and validation of the Quick COVID-19 Severity Index: A prognostic tool for early clinical decompensation. Ann Emerg Med., 76:442-53.</p></li><li><p>Bischoff-Ferrari H, Giovannucci E, Willett W et al. (2006): Estimation of optimal serum concentrations of 25- hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr., 84:18-28.</p></li><li><p>Westergren A (1926): The technique of the red cell sedimentation reaction. American Review of Tuberculosis, 14:94-101.</p></li><li><p>Meltzer D, Best T, Zhang H et al. (2020): Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA Netw Open, 3:e2019722.</p></li><li><p>Martineau A, Jolliffe D, Hooper R et al. (2017): Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ., 356:i6583.</p></li><li><p>Dixon B, Barker T, McKinnon T et al. (2012): Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res Notes, 5:575.</p></li><li><p>Zdrenghea M, Makrinioti H, Bagacean C et al. (2017): Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol., 27:45-49.</p></li><li><p>Jakovac H (2020): COVID-19 and vitamin D-Is there a link and an opportunity for intervention? Am J Physiol Endocrinol Metab., 318:E589.</p></li><li><p>Maghbooli Z, Sahraian M, Ebrahimi M et al. (2020): Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One, 15:e0239799.</p></li><li><p>Rastogi A, Bhansali A, Khare N et al. (2022): Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study). Postgrad Med J., 98:87-90.</p></li><li><p>Tellioglu A, Basaran S, Guzel R et al. (2012): Efficacy and safety of high dose intramuscular or oral cholecalciferol in vitamin D deficient/insufficient elderly. Maturitas, 72:332-8.</p></li><li><p>Amrein K, Sourij H, Wagner G et al. (2011): Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo­controlled pilot study. Crit Care, 15:R104.</p></li><li><p>Kearns M, Alvarez J, Tangpricha V (2014): Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review. Endocr Pract., 20:341­51.</p></li><li><p>Velavan T, Meyer C (2020): Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis., 95:304-7.</p></li></ol></article></div></div><script src="/js/lightspa.js?v=1748384335"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748384335",indexUrl:"/search/search_index.json.gz?v=1748384335"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748384335"></script><script src="/js/search-results-panel.js?v=1748384335"></script><script src="/js/tiki-redirects.js?v=1748384335"></script></body></html>